Journalist

&
""
Latest by
November Exports Surge 112% to $33.4 Billion, Approaching $1 Trillion Milestone
November Exports Surge 112% to $33.4 Billion, Approaching $1 Trillion Milestone

South Korea's exports in early November more than doubled compared to a year ago, setting a record for the month. The cumulative export amount for the year has surpassed $960 billion, bringing the country closer to its first annual export total of $1 trillion.According to the Korea Customs Service, the preliminary export figure for November 1-10 was $33.46 billion, a 111.9% increase from the same period last year. This marks the highest amount recorded for the first ten days of November.Considering the number of working days, the average daily export amount was $4.46 billion, up 97.7% from $2.26 billion during the same period last year. Even accounting for an increase of 0.5 working days, the growth in exports is significant.This brings the cumulative export total for the year to $963.663 billion, a 62.0% increase compared to the same period last year. Only $36.337 billion remains to reach the historic $1 trillion annual export goal.Earlier, the Ministry of Trade, Industry and Energy projected on November 1 that the annual export total would likely exceed $1 trillion in November. With an average daily export amount of $4.46 billion, it is anticipated that exports could surpass $1 trillion as early as November 20.The surge in exports was primarily driven by semiconductors. In early November, semiconductor exports reached $16.632 billion, a staggering 331.2% increase from the same period last year. This figure represents the highest amount recorded for the first ten days of the month, with semiconductors accounting for 49.7% of total exports, an increase of 25.3 percentage points from the previous year.Other major export items also saw increases. Due to rising prices from high oil costs, petroleum product exports rose to $2.012 billion, a 100.7% increase, while exports of computer peripherals surged to $1.046 billion, a 237.7% increase. Exports of steel products (38.8%), ships (63.9%), and wireless communication devices (35.1%) also showed growth. However, passenger car exports decreased by 4.3% to $1.474 billion.By country, exports to China increased by 148.0% to $9.163 billion, while exports to the United States rose by 163.6% to $6.797 billion. Other key trading partners, including Vietnam (113.3%), Taiwan (182.5%), and the European Union (20.0%), also experienced growth. The combined export share from China, the U.S., and Vietnam accounted for 57.3% of total exports.Imports totaled $24.71 billion, a 45.0% increase from the previous year. Semiconductor imports rose by 101.3% to $4.688 billion, while imports of crude oil (75.8%), gas (192.1%), semiconductor manufacturing equipment (36.4%), and machinery (16.5%) also increased.Energy imports, including crude oil, gas, and coal, rose by 86.3% compared to a year ago. Crude oil imports amounted to $3.253 billion, while gas imports reached $1.404 billion. In contrast, coal imports decreased by 3.0% to $341 million.By country, imports increased from China (63.8%), the United States (35.3%), the EU (9.0%), Taiwan (77.8%), and Japan (28.0%).With exports exceeding imports, the trade balance for early November recorded a surplus of $8.751 billion, a turnaround from a deficit of $1.241 billion during the same period last year. The cumulative trade surplus for the year has expanded to $303.739 billion.* This article has been translated by AI.

CJ CheilJedang Introduces Physical AI in Food Manufacturing for Autonomous Production
CJ CheilJedang Introduces 'Physical AI' in Food Manufacturing for Autonomous Production

CJ CheilJedang is set to develop technology that utilizes artificial intelligence (AI) to automatically manage and control food production processes. The company plans to enhance productivity and quality competitiveness by applying AI throughout the manufacturing site, including real-time detection of product defects and predictive maintenance of equipment.On November 11, CJ CheilJedang announced its participation as a representative company in the food sector for the Ministry of Trade's 'AI Factory Support Project.'The core of this initiative is the development of 'Physical AI' technology that controls actual equipment and processes. CJ CheilJedang will collaborate with WonPredict, Ivex, and the Korea Institute of Industrial Technology to create autonomous manufacturing and integrated predictive maintenance technologies tailored for the food and beverage (F&B) industry.Initially, the company will establish a foundation for real-time data collection and analysis from various equipment in the manufacturing environment. Based on this, it plans to apply 'Physics-Informed Neural Networks (PINN)' technology to learn the physical characteristics of processes and sensor data, predicting optimal equipment operating conditions and automatically controlling production processes.AI will also be utilized in quality management. By combining machine vision that assesses product conditions with robotics and edge AI technology that processes data on-site, the system will detect foreign substances, product damage, and packaging defects in real time. If anomalies are identified, the system will respond by coordinating with equipment control to address defects.In equipment management, AI will analyze the operational status of machinery to detect signs of failure in advance, establishing a predictive maintenance system that minimizes unexpected production line shutdowns.AI CCTV will respond to situations where workers collapse or enter hazardous areas. The technology will develop safety control measures that automatically slow down or stop production equipment upon detecting dangerous situations in real time, thereby preventing industrial accidents.CJ CheilJedang plans to integrate these technologies using the digital transformation (DX) foundation established through its existing smart factory and production automation systems. The goal is to implement an autonomous manufacturing system where AI recognizes the state of the production site, predicts anomalies, and determines necessary actions, including equipment control.Kang Min-soo, Vice President of Production at CJ CheilJedang, stated, "In food manufacturing, the characteristics of raw materials and changes in the production environment directly affect product quality. Therefore, AI technology that understands both on-site data and process characteristics is crucial. We aim to secure Physical AI technology optimized for F&B manufacturing to enhance productivity, quality, and safety competitiveness, while also strengthening the global competitiveness of K-food."* This article has been translated by AI.

Shift Up Shares Drop 9% Amid Q3 Earnings Shock and Growth Concerns
Shift Up Shares Drop 9% Amid Q3 Earnings Shock and Growth Concerns

Shift Up's shares have plunged in early trading due to a sharp decline in operating profit and a transition to a net loss for the third quarter. The postponement of the announcement schedule for its upcoming title has further fueled uncertainty regarding future growth.According to the Korea Exchange, Shift Up's stock was trading at 28,500 won, down 2,850 won (9.09%) from the previous trading day. The stock opened at 29,750 won and fell further to a low of 28,450 won during the session.Earlier, Shift Up disclosed that its operating profit for the third quarter was 20.7 billion won, a 58.2% decrease compared to the same period last year. The company reported a net loss of 25.5 billion won, marking a shift to a deficit.Analysts suggest that not only the short-term performance slump but also the absence of new titles is limiting medium- to long-term growth expectations. Kim So-hye, a researcher at Hanwha Investment & Securities, stated, "Both performance and new title momentum have been in a hiatus for a long time, and market expectations have significantly lowered. While a rebound in existing IP sales is anticipated in the fourth quarter, the business direction that will drive growth after next year has yet to be clarified."She added, "The disclosure of information regarding upcoming titles remains crucial. Although there was a goal to reveal details about the new project 'Spirit' within this year, the timeline has been pushed to next year due to the release schedules of competing titles." She concluded that once the details and release schedule for 'Spirit' are clarified, the stock is expected to gain upward momentum.* This article has been translated by AI.

Hanjin Shares Surge Nearly 17% After Announcing Stock Buyback
Hanjin Shares Surge Nearly 17% After Announcing Stock Buyback

Hanjin's decision to retire all of its treasury shares has led to a nearly 17% surge in its stock price. This shareholder return measure, which reduces the total number of outstanding shares by about 3%, is seen as a positive move for the company's stock.According to the Korea Exchange, as of 9:31 a.m. on November 11, Hanjin's shares were trading at 21,400 won, up 3,120 won (16.97%) from the previous trading day.On November 10, Hanjin's board of directors announced the decision to retire 478,401 common shares, with a total book value of approximately 19.99 billion won.The shares being retired represent 3.07% of the company's total outstanding shares. Of these, 478,399 shares were acquired in accordance with Article 341 of the Commercial Act, while the remaining two shares were acquired for specific purposes during a stock consolidation process.As a result of this retirement, the total number of outstanding shares will decrease from 15,566,499 to 15,088,098. However, since the shares being retired are already held as treasury stock, there will be no change in the company's capital. The retirement is scheduled for November 30.Hanjin stated that this treasury stock retirement is aimed at enhancing shareholder value.A company representative remarked, "This stock retirement decision is intended to boost market confidence and effectively enhance shareholder value. We will continue to pursue strategies that increase corporate value and foster shareholder-friendly management."* This article has been translated by AI.

Kakao Navi Enhances Commute Alerts and Traffic Information
Kakao Navi Enhances Commute Alerts and Traffic Information

Kakao Mobility has revamped the home and driving screens of Kakao Navi to help drivers check traffic conditions before departure and identify congestion and fork information while driving.On November 11, Kakao Mobility announced it is enhancing its 'proactive traffic guidance' feature to allow drivers to assess road conditions in advance. The core of this update is a complete overhaul of Kakao Navi's home and driving screens.When the app is launched, the home screen now provides immediate access to traffic conditions for the commute. A fixed destination card at the top of the home screen automatically displays traffic updates for the workplace in the morning and home in the evening. If the estimated travel time increases by more than five minutes compared to usual, it summarizes specific road conditions, such as '20 minutes longer than usual' or '18 minutes delay due to an accident on the Dongbu Expressway, 2.8 km of congestion.' This allows users to assess traffic conditions before departure and plan their travel accordingly.The guidance for congestion areas while driving has also been strengthened. Previously, detailed information could only be accessed upon entering a congested area, but now drivers can check congestion information in advance while driving.Improvements have also been made to lane change and fork guidance features. If congestion occurs two kilometers before an exit, the app will suggest 'recommended entry into the right lane' to help drivers change lanes in advance. Conversely, if the immediate fork is congested but the exit point is clear, it will provide guidance such as 'recommended lane change to lane five one kilometer back.' This approach encourages drivers to change lanes at appropriate times without unnecessarily joining a line of congestion.A representative from Kakao Mobility stated, “Kakao Navi is not just a simple navigation tool; it is a core component of the Kakao T ecosystem that leads to actual business through hailing and payment. We aim to maximize the proactivity and intuitiveness of navigation to ensure that both drivers and business partners can rely on us as the most trusted guide.”* This article has been translated by AI.

Lotte Chemical and Dong-A Pharmaceutical Among Eight Recognized for Arts Sponsorship
Lotte Chemical and Dong-A Pharmaceutical Among Eight Recognized for Arts Sponsorship

The Ministry of Culture, Sports and Tourism and the Korea Arts Council (ARKO) announced on November 11 that they held a certification ceremony for the '2026 Arts Sponsorship Organizations and Excellent Arts Sponsorship Institutions' at the Westin Chosun Hotel in Seoul on November 10, recognizing eight organizations for their contributions to arts sponsorship.This year, the newly certified organizations include two sponsorship organizations, the Gwanak Cultural Foundation and the Gyeonggi Cultural Foundation, and six excellent sponsorship institutions: Golfzon, Myeonsarang, Lotte Chemical, Dong-A Pharmaceutical, Korea Maritime Promotion Corporation, and Korea Midland Power. Including re-certified institutions, a total of 81 organizations currently maintain their certification.The newly certified organizations have been actively engaged in sponsorship activities tailored to their respective business characteristics. Golfzon operates a choir for people with disabilities, supporting employment and artistic activities for disabled artists. Myeonsarang has sponsored the orchestra of a middle school in Jincheon, Chungbuk Province, for the 22nd consecutive year. Korea Midland Power has provided a cultural space in the Seoul Thermal Power Plant, laying the groundwork for the creation of the 'Danginri Cultural Creation Power Plant.' The Korea Maritime Promotion Corporation introduced a new sponsorship model called 'Marine Mecenat,' featuring events like the Marine Art Festival and Marine Music Festival.Notably, Olympus Korea, Chong Kun Dang Holdings, Shinsegae, the Gyeongnam Mecenat Association, and the Korea Mecenat Association have maintained their certification for 11 years since the program's inception in 2015. They are recognized for demonstrating exemplary long-term and sustainable support for arts and culture beyond one-time sponsorships.Olympus Korea and Hyundai Marine & Fire Insurance were awarded the Minister's Prize for their contributions to arts sponsorship.Lee Beom-hun, chairman of ARKO, stated, 'From the institutions that have maintained their certification for 11 years to those newly certified this year, the support shown by these certified organizations is a strong force sustaining the arts scene. We will continue to strengthen support so that certified organizations can gain greater recognition for the value of their sponsorship.'Certified organizations receive a certificate from the Minister of Culture, benefits for using the certification mark, preferential immigration cards, and interest rate benefits from KB Kookmin Bank (for small and medium-sized enterprises).* This article has been translated by AI.

KDB Life Launches New Whole Life Insurance Combining Death Benefits and Retirement Planning
KDB Life Launches New Whole Life Insurance Combining Death Benefits and Retirement Planning

KDB Life has introduced a new whole life insurance product that combines death benefits with retirement funding options.The company announced the launch of the 'More! Happy Plus Whole Life Insurance (Non-participating)' on November 11.This product features a death benefit that increases by 10% each year for the first 10 years after enrollment. After 10 years, the death benefit will reach 200% of the initial insured amount.The increasing death benefit structure is designed to counteract the potential decrease in the real value of the death benefit due to rising inflation.Policyholders can choose between a 10-year or 20-year premium payment period. Upon completion of premium payments, a completion bonus will be added to both the death benefit and the surrender value. A long-term maintenance bonus will also be credited at the 20-year mark for 10-year premium payers and at the 25-year mark for 20-year premium payers.Additionally, the policy includes an option for converting the surrender value into an annuity through the 'Guaranteed Annuity Conversion Rider.' This allows policyholders to maintain death coverage while deciding on annuity conversion based on their financial situation after retirement.A KDB Life representative stated, "This product is designed to enhance the core death benefit function of whole life insurance while providing additional benefits for customers who maintain long-term contracts. We expect it to serve as a protective asset for families during their working years and as a source of retirement funds afterward."* This article has been translated by AI.

Korean biotechs pitch cancer drugs at BIO-Europe
Korean biotechs pitch cancer drugs at BIO-Europe

ZURICH, November 10 (AJP) - South Korean biotech firms are pitching cancer treatments, liver disease drugs and drug-delivery technologies to global pharmaceutical companies at BIO-Europe in Cologne, seeking partners to finance development and reach overseas markets. Licensing, joint development and investment discussions continued Tuesday as the three-day event entered its second day. No Korean company had announced a signed agreement by then, according to the Korean media reports cited, though negotiations typically extend well beyond the initial meetings. Cellbion is presenting clinical results for Lu-177-DGUL, an experimental radiopharmaceutical for advanced prostate cancer. The treatment delivers radiation to cancer cells using an approach similar to that of Pluvicto, developed by Swiss drugmaker Novartis. The company reported an objective response rate — the proportion of patients whose tumors shrank sufficiently to meet specified criteria — of 35.9 percent in a South Korean phase two trial. The rate was 47.4 percent among patients with measurable lesions. South Korea’s Ministry of Food and Drug Safety approved a phase three trial in September. Cellbion is also studying the treatment in combination with Keytruda, the cancer immunotherapy made by U.S. drugmaker Merck, known as MSD outside the United States and Canada. The company said it was following up on contacts made at BIO-Japan in October and hoped to “expand practical global business development opportunities, including technology transfers and co-development.” D&D Pharmatech is pursuing discussions on DD01, a once-weekly injection being developed for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease involving fat buildup, inflammation and damage. In its U.S. phase two trial, 62.5 percent of DD01 recipients achieved MASH resolution without worsening liver scarring after 48 weeks, compared with 5.3 percent of placebo recipients. Those results came from an analysis of 35 patients who followed the trial protocol and completed both required biopsies, including 16 who received DD01, according to the company. LigaChem Biosciences is discussing partnerships for its antibody-drug conjugates (ADCs), which pair antibodies that recognize cancer cells with potent anticancer drugs. The company also plans to attend an investment conference in London next week. ABL Bio is exploring the application of its brain drug-delivery technology to medicines based on short strands of genetic material. Alteogen and its subsidiary Alteogen Biologics are seeking partners for ALTS-OP01, an experimental treatment for retinal disease. Other Korean participants include Pharos iBio, which is presenting two cancer drug candidates, and Aptabio, which is seeking partners for a treatment intended to prevent kidney injury associated with contrast agents used in medical imaging. KoBioLabs is promoting technology that uses microbes to deliver therapeutic substances inside the body. In March, it signed a licensing agreement with Celltrion worth up to 205.2 billion won, including payments contingent on development and commercial milestones. For Korean biotech firms, international partnerships can provide funding for expensive late-stage trials and access to regulatory expertise and overseas sales networks. ABL Bio’s licensing agreements with Britain’s GSK and U.S. drugmaker Eli Lilly in 2025 illustrate the potential commercial value of drug-delivery platforms alongside individual medicines. BIO-Europe concludes Wednesday. The longer test for participating companies will be whether contacts made in Cologne progress through scientific review and commercial negotiations into development partnerships. - Tags: BIO-Europe, South Korea, biotech, Cellbion, Lu-177-DGUL, Novartis, Merck, Keytruda, D&D Pharmatech, LigaChem Biosciences, ABL Bio, Alteogen, Pharos iBio, Aptabio, KoBioLabs, Celltrion, Cologne, licensing

BaroPharm Shares Drop Over 20% on First Day of KOSDAQ Listing
BaroPharm Shares Drop Over 20% on First Day of KOSDAQ Listing

BaroPharm, a pharmacy integration platform company, is trading more than 20% below its offering price on its first day of KOSDAQ listing on November 11.According to the Korea Exchange, as of 9:21 a.m., BaroPharm's shares were priced at 13,090 won, down 3,310 won (20.18%) from the offering price of 16,400 won.Founded in 2019 by current pharmacist CEO Kim Seul-ki, BaroPharm provides essential services for pharmacy operations, including an integrated drug ordering solution, payment processing, returns, opening support, and AI drug identification.During the IPO process, investor demand was relatively low. In the institutional investor demand forecast held from October 22 to 28, the company recorded a competition ratio of 152.36 to 1, confirming the offering price at the lower end of the desired range at 16,400 won. The subscription competition ratio for general investors during the offering period from November 2 to 3 was 19.27 to 1, with approximately 70.3 billion won in subscription deposits collected. Mirae Asset Securities acted as the lead underwriter for the KOSDAQ listing.The company has secured approximately 24,787 subscribers, representing about 90% of pharmacies nationwide. The cumulative integrated order connection amount is 7.2 trillion won, with a reorder rate of 86%. BaroPharm is expanding its reach beyond the platform business into direct purchases from pharmaceutical companies, beauty product distribution, and its own brand initiatives.BaroPharm's performance continues to grow, with sales reaching 96.7 billion won last year, a significant increase from about 300 million won in 2021. In the first half of this year, the company recorded sales of 69 billion won and an operating profit of 2.2 billion won, marking a return to profitability.The company plans to invest the funds raised from this offering into AI technology, international brand expansion, and the establishment of pharmaceutical production facilities. This strategy aims to broaden its business scope beyond pharmacy platforms into the overall healthcare sector.CEO Kim Seul-ki stated, "BaroPharm has grown through a network of pharmacies where our platform, partnerships, and brand initiatives support each other. With our KOSDAQ listing, we aim to innovate the pharmacy platform and shape the future of healthcare."* This article has been translated by AI.

MoaData Shares Plunge Nearly 26% on First Day of Trading After Stock Consolidation
MoaData Shares Plunge Nearly 26% on First Day of Trading After Stock Consolidation

코스닥 상장사 모아데이타가 주식 액면병합을 마치고 거래를 재개한 첫날 26% 가까이 급락하고 있다. On November 11, at 9:22 a.m., MoaData shares were trading at 755 won, down 265 won (25.98%) from the reference price of 1,020 won. According to the Korea Exchange, MoaData resumed trading today after completing the listing process for its changed shares following the stock consolidation. Trading had been halted from October 20 to November 10. MoaData initiated the stock consolidation to stabilize its share price and enhance shareholder value, merging five common shares into one. As a result, the par value per share increased from 500 won to 2,500 won, and the total number of shares decreased from 37,523,583 to 7,504,716. Stock consolidation reduces the number of shares by combining multiple shares into one. While this action does not inherently change the company's value, MoaData has experienced a significant decline on its first day of trading after the consolidation. The company previously faced issues after changing the consolidation ratio from 2-for-1 to 5-for-1, leading to its designation as an unreliable disclosure corporation on November 5. The Korea Exchange imposed a penalty of 4.0 points for altering the consolidation ratio by more than 20%. On the last trading day before the consolidation, October 19, MoaData's closing price was 204 won. Adjusted for the consolidation ratio, this equates to 1,020 won; however, the stock price fell below 1,000 won shortly after trading resumed, undermining the initial goal of price stabilization.* This article has been translated by AI.